159
Participants
Start Date
May 19, 2020
Primary Completion Date
April 29, 2022
Study Completion Date
April 29, 2022
Verinurad
"The treatment will be titrated in 3 steps for target low dose (3 mg), intermediate dose (7.5 mg) and high dose (12mg) of verinurad.~Drug: Allopurinol The treatment will be titrated in 3 steps. Low dose (100mg), intermediate (200mg) and high dose (300mg) of allopurinol."
Allopurinol
Study treatments will be titrated in 3 steps: Low dose (100mg), intermediate (200mg) and high dose (300mg) of allopurinol
Placebo for verinurad
Matching Capsule
Placebo for allopurinol
Matching tablet
Research Site, Sofia
Research Site, Vienna
Research Site, Sofia
Research Site, Rosario
Research Site, Geelong
Research Site, Plovdiv
Research Site, Chermside
Research Site, Milton
Research Site, Bedford Park
Research Site, Mar del Plata
Research Site, Graz
Research Site, Berlin
Research Site, Berlin
Research Site, Norfolk
Research Site, Gangwon-do
Research Site, Winston-Salem
Research Site, Cheongju-si
Research Site, Port Orange
Research Site, Bad Oeynhausen
Research Site, Pembroke Pines
Research Site, Miami
Research Site, Göttingen
Research Site, Querétaro
Research Site, Torrance
Research Site, Northridge
Research Site, Granada Hills
Research Site, Regensburg
Research Site, Würzburg
Research Site, Brezno
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Aramil
Research Site, Novosibirsk
Research Site, Tomsk
Research Site, Kemerovo
Research Site, CABA
Research Site, CABA
Research Site, CABA
Research Site, Mar del Plata
Research Site, Québec
Research Site, Québec
Research Site, Québec
Research Site, Québec
Research Site, Bydgoszcz
Research Site, Chojnice
Research Site, Chrzanów
Research Site, Lublin
Research Site, Tychy
Research Site, Warsaw
Research Site, Warsaw
Research Site, Warsaw
Research Site, Lučenec
Research Site, Prešov
Research Site, Svidník
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Lead Sponsor
AstraZeneca
INDUSTRY